A Study to Test the Use of the E-PAL Mobile Application for Pain Management in Cancer Patients

Overview

About this study

The investigators have developed a mobile application (for use on smart phones) to help cancer patients better manage cancer pain. The purpose of this study is to evaluate the effect of this mobile-based intervention. The intent is that subjects will achieve greater reductions in cancer-related pain and improved quality of life.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • 18 years and older
  • Has solid-organ cancer
  • Diagnosed with moderate or severe cancer pain
    • Pain intensity score of at least 4/10 on numeric rating scale at Massachusetts General Hospital Palliative Care Center
    • Determined by the patient's care provider
    • Do not need to experience a specific nature of pain
  • Must be ambulatory and not currently admitted to the hospital at time of enrollment
  • For phase II, must have a smart phone and be willing to download the study application
  • Must be able to read and speak English

Exclusion Criteria

  • A life expectancy of less than 2-months as determined by the palliative care provider 
  • Significant medical or psychiatric co-morbidities (other than depression or anxiety) or cognitive impediments that would prevent participant from being able to utilize the program 
  • Known history of substance abuse
  • Currently on investigational therapies or other study protocols that may have an impact on pain intensity or quality of life which are main outcomes of this intervention

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Jacob Strand, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20230337

Mayo Clinic Footer